Dataset Information

MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

ABSTRACT: MicroRNA-155 (miR-155) is a small noncoding RNA critical for the regulation of inflammation as well as innate and adaptive immune responses. MiR-155 has been shown to be dysregulated in both donor and recipient immune cells during acute graft-versus-host disease (aGVHD). We previously reported that miR-155 is upregulated in donor T cells of mice and humans with aGVHD and that mice receiving miR-155-deficient (miR155-/-) splenocytes had markedly reduced aGVHD. However, molecular mechanisms by which miR-155 modulates T cell function in aGVHD have not been fully investigated. We identify that miR-155 expression in both donor CD8+ T cells and conventional CD4+ CD25- T cells is pivotal for aGVHD pathogenesis. Using murine aGVHD transplant experiments, we show that miR-155 strongly impacts alloreactive T cell expansion through multiple distinct mechanisms, modulating proliferation in CD8+ donor T cells and promoting exhaustion in donor CD4+ T cells in both the spleen and colon. Additionally, miR-155 drives a proinflammatory Th1 phenotype in donor T cells in these two sites, and miR-155-/- donor T cells are polarized toward an IL-4-producing Th2 phenotype. We further demonstrate that miR-155 expression in donor T cells regulates CCR5 and CXCR4 chemokine-dependent migration. Notably, we show that miR-155 expression is crucial for donor T cell infiltration into multiple target organs. These findings provide further understanding of the role of miR-155 in modulating aGVHD through T cell expansion, effector cytokine production, and migration.

SUBMITTER: Zitzer NC

PROVIDER: S-EPMC5988971 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Zitzer Nina C NC Snyder Katiri K Meng Xiamoei X Taylor Patricia A PA Efebera Yvonne A YA Devine Steven M SM Blazar Bruce R BR Garzon Ramiro R Ranganathan Parvathi P

Journal of immunology (Baltimore, Md. : 1950) 20180502 12

MicroRNA-155 (miR-155) is a small noncoding RNA critical for the regulation of inflammation as well as innate and adaptive immune responses. MiR-155 has been shown to be dysregulated in both donor and recipient immune cells during acute graft-versus-host disease (aGVHD). We previously reported that miR-155 is upregulated in donor T cells of mice and humans with aGVHD and that mice receiving miR-155-deficient (miR155<sup>-/-</sup>) splenocytes had markedly reduced aGVHD. However, molecular mechan ...[more]

PMID: 29720426

Similar Datasets

Project description:Allogeneic hematopoietic stem cell transplantation is a curative treatment for numerous hematological malignancies. However, acute graft-versus-host disease (aGvHD) is a major complication affecting 40-70% of all transplant patients, whereby the earliest and most frequent presentation is in the skin. MicroRNAs play a role in varied biological process and have been reported as potential biomarkers for aGvHD. More recently, microRNAs have received added attention as circulatory biomarkers that can be detected in biofluids. In this study, we performed global microRNA expression profiling using a discovery cohort of diagnostic cutaneous aGvHD biopsies (n?=?5, stages 1-3) and healthy volunteers (n?=?4), in order to identify a signature list of microRNAs that could be used as diagnostic biomarkers for cutaneous aGvHD. Candidate microRNAs (n?=?8) were then further investigated in a validation cohort of post-HSCT skin biopsies (n?=?17), pre-HSCT skin biopsies (n?=?6) and normal controls (n?=?6) for their association with aGvHD. Expression of let-7c (p?=?0.014), miR-503-5p (p?=?0.003), miR-365a-3p (p?=?0.02), miR-34a-5p (p?<?0.001) and miR-34a-3p (p?=?0.006) were significantly differentially expressed between groups and significantly associated with survival outcome in post-HSCT patients (miR-503-5p ROC AUC?=?0.83 p?=?0.021, Log Rank p?=?0.003; miR-34a-3p ROC AUC?=?0.93, p?=?0.003, Log Rank p?=?0.004). There was no association with relapse. A statistical interaction between miR-34a-3p and miR-503-5p (p?=?0.016) was diagnostic for aGvHD. Expression levels of the miR-34a-5p protein target p53 were assessed in the epidermis of the skin, and an inverse correlation was identified (r2?=?0.44, p?=?0.039). Expression of the validated candidate microRNAs was also assessed at day 28 post-HSCT in the sera of transplant recipients, in order to investigate their potential as circulatory microRNA biomarkers. Expression of miR-503-5p (p?=?0.001), miR-34a-5p (p?=?0.005), and miR-34a-3p (p?=?0.004) was significantly elevated in the sera of patients who developed aGvHD versus no-aGvHD (n?=?30) and miR-503-5p was associated with overall survival (OS) (ROC AUC?=?0.80, p?=?0.04, Log Rank p?=?0.041). In conclusion, this investigation reports that microRNA expression levels in clinical skin biopsies, obtained at the time of cutaneous aGvHD onset, show potential as diagnostic biomarkers for aGvHD and as predictive biomarkers for OS. In addition, the same microRNAs can be detected in the circulation and show predictive association with post-HSCT outcomes.

Dataset Information

MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Publications

MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets